Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran.

[1]  M. Busch,et al.  New Strategies for Blood Donor Screening for Hepatitis B Virus , 2012, Molecular Diagnosis & Therapy.

[2]  M. Aslan,et al.  Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. , 2010, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[3]  A. Zanetti,et al.  A 2010 update on occult hepatitis B infection. , 2010, Pathologie-biologie.

[4]  A. Eslamifar,et al.  Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  J. Allain,et al.  Transfusion-transmitted hepatitis B virus infection. , 2009, Journal of hepatology.

[6]  Bao-cheng Yang,et al.  Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[7]  Alavian SeyedMoayed,et al.  Hepatitis B Virus Infection in Iran: A Systematic Review , 2008 .

[8]  M. Mirzaei,et al.  OCCULT HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS WITH ANTIBODIES TO HEPATITIS B CORE ANTIGEN , 2008 .

[9]  Joukar Farahnaz,et al.  Prevalence of Hepatitis B Surface Antigen and Hepatitis C Virus Antibody and Their Risk Factors among Guilan's Volunteer Blood Donors (1998-2003) , 2007 .

[10]  M. Moghtadaei,et al.  DETECTION OF HEPATITIS B VIRUS DNA (PCR) IN HBSAG NEGATIVE, ANTI-HBC POSITIVE BLOOD DONORS IN TEHRAN PROVINCE , 2007 .

[11]  G. Raimondo,et al.  Occult hepatitis B virus infection. , 2007, Journal of hepatology.

[12]  P. Holland,et al.  Hepatitis B virus blood screening: unfinished agendas , 2006, Vox sanguinis.

[13]  Ding‐Shinn Chen,et al.  Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  K. Lankarani,et al.  Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. , 2006, The Indian journal of medical research.

[15]  M. Arababadi,et al.  Detection of HBV DNA in HBsAg Negative Normal Blood Donors , 2005 .

[16]  J. Allain.  Occult hepatitis B virus infection. , 2004, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[17]  Ding‐Shinn Chen,et al.  Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers , 2002, Transfusion.

[18]  M. Torbenson,et al.  Occult hepatitis B. , 2002, The Lancet. Infectious diseases.

[19]  K. Hu.  Occult hepatitis B virus infection and its clinical implications , 2002, Journal of viral hepatitis.

[20]  M. Busch,et al.  HBV: amplified and back in the blood safety spotlight , 2001, Transfusion.

[21]  M. Chevallier,et al.  High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. , 2001, Journal of hepatology.

[22]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[23]  S. Kleinman,et al.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. , 1996, The New England journal of medicine.